SavedAdd your journal

Journals / Çukurova Anestezi ve Cerrahi Bilimler Dergisi / 2020 / Cilt: 3 - Sayı: 3

Although pharmacological treatment is successful in smoking cessation, what are the factors that reduce patients compliance to drugs

Pelin DURU ÇETİNKAYA
Perihan ÇETİNKAYA
Kevser MELEK
Pages
155–161
Publication Date
2020-12-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Considering the rate of quitting after one year, it was found that 33.8% of them quit smoking.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Pharmacological treatment has been shown to increase success in moderate and high nicotine addicts.Although the success of quitting is even higher with three months of regular treatment, the rates of using the treatment are low.In this study, although it was emphasized that patients should use 3 months of regular treatment, the reasons for not using pharmacological treatment were investigated.
📊
Key Findings & Data:Methods: One year after the initiation of smoking cessation treatment, the patients were called at least 3 times, and a questionnaire was conducted with the verbal consent of 281 patients.
💡
Conclusion & Impact:Considering the rate of quitting after one year, it was found that 33.8% of them quit smoking.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Treatment Compliance · Pharmacological Treatment · Nicotine Addiction

Özet

Objectives: Pharmacological treatment has been shown to increase success in moderate and high nicotine addicts.Although the success of quitting is even higher with three months of regular treatment, the rates of using the treatment are low.In this study, although it was emphasized that patients should use 3 months of regular treatment, the reasons for not using pharmacological treatment were investigated. Methods: One year after the initiation of smoking cessation treatment, the patients were called at least 3 times, and a questionnaire was conducted with the verbal consent of 281 patients. Results: A total of 277 (%70.1) of 395 cases included in the study were male and their mean age was 41.35 ± 11.6 (18--79) years.When the duration of treatment use of 281 cases was questioned, it was seen that only 108 (38.4%) completed the treatment. Some patients not used the drugs due to side effects of the drugs (30.6%), some patients (20.2%) thought that the medication will not be effective, some patients (19.7%) thought that they weren't ready to quit, some patients (16.2%) thought that they quit smoking already. Considering the rate of quitting after one year, it was found that 33.8% of them quit smoking. Conclusion: Although studies have shown that 3 months of regular pharmacological treatment in smoking cessation treatment increases the success of quitting and decreases relapse, it was found that 61.6% of the patients did not use the treatment for three month.

🔖

Cite This Article

ÇETİNKAYA, P. D., ÇETİNKAYA, P., MELEK, K. (2020). Although pharmacological treatment is successful in smoking cessation, what are the factors that reduce patients compliance to drugs. Çukurova Anestezi ve Cerrahi Bilimler Dergisi, Cilt: 3 - Sayı: 3, 155–161. https://ajindex.com/articles/483852

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Dilektaşlı, A.G., Bostan P.P.,., & Salepçi, B. (2020). Turkey and Tobacco Control. Sted. 29, special issue, 36-42
  2. Bilir, N. (2009). Level of tobacco control in Turkey. Turkish Thoracic Journal, 10, 31-34
  3. Law on the Prevention of Harmful Effects of Tobacco Products, No 4207, Official Gazette No. 22829 of 26 November 1996 (inTurkish).
  4. Elbek, O. (2010). National Legislation on Tobacco Control. Ed: Aytemur, Z.A., Akçay, Ş., Elbek, O. Tobacco and Tobacco Control. Toraks books. Issue 10. Aves Publishing, 52-73
  5. Akçay, M.Ş. (2012). Sigara Bırakma Polikliniklerinin Yapılandırılması. Türkiye Klinikleri Göğüs Hastalıkları-Özel Konular, 5(2), 29-34
  6. Çetinkaya, P. D., Batum, Ö., Kararmaz, E. A., Turan, A., Çetinkaya, P., & Çetinkaya, F. (2020). Compliance With The Legislation Of The Smoking Cessation Clinic In Turkey. Turkish Thoracic Journal
  7. Anthenelli, R. M., Benowitz, N. L., West, R., St Aubin, L., McRae, T., Lawrence, D.,. & Evins, A. E. (2016). Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. The Lancet, 387(10037), 2507-2520
  8. Abdul-Kader, J., Airagnes, G., D'almeida, S., Limosin, F., & Le Faou, A. L. (2018). Interventions for smoking cessation in 2018. Revue de pneumologie clinique, 74(3), 160
  9. Kılınç O. (2010) Behavioral and cognitive methods in smoking cessation treatment. Tobacco and Tobacco Control, 2nd ed.(Eds Aytemur ZA, Akçay Ş, Elbek O), 479-484
  10. Demir T. (2010) Constitutions of smoking cessation clinics. Tobacco and Tobacco Control, 2nd ed.(Eds Aytemur ZA, Akçay Ş, Elbek O), 439-444
  11. Larzelere, M. M., & Williams, D. E. (2012). Promoting smoking cessation. American family physician, 85(6), 591-598
  12. Marlow, S. P., & Stoller, J. K. (2003). Smoking cessation. Respiratory care, 48(12), 1238-1256
  13. Shearer, J., & Shanahan, M. (2006). Cost effectiveness analysis of smoking cessation interventions. Australian and New Zealand journal of public health, 30(5), 428-434
  14. Çelik, İ., Yüce, D., Hayran, M., Erman, M., Kılıçkap, S., Buzgan, T.,. & Akdağ, R. (2015). Nationwide smoking cessation treatment support program–Turkey project. Health Policy, 119(1), 50-56
  15. Hollands, G. J., Naughton, F., Farley, A., Lindson, N., & Aveyard, P. (2019). Interventions to increase adherence to medications for t